Læknaneminn - 01.04.1997, Síða 138

Peter Duesberg and David Rasnick
1981-1988, in Drug Addiction and AIDS, N. Loimer, R. Schmid
and A. Springer (eds.) Springer-Verlag, New York, 1991; 16-22.
308. Piischel K, Mohsenian F. HIV-1-prevalence among drug deaths in
Germany, in Drug Addiction and AIDS, N. Loimer, R. Schmid and
A. Springer (eds.) Springer-Verlag, New York, 1991; 89-96.
309. Bschor F, Bornemann R, Borowski C, Schneider V. Monitoring of
HlV-spread in regional populations of injecting drug users—the
Berlin experience, in Drug Addiction and AIDS, N. Loimer, R.
Schmid and A. Springer (eds.) Springer-Verlag, New York, 1991;
102-109.
310. Mientjes GH, Miedema F, van Ameijden EJ, van den Hoek AA,
Schellekens PTA, Roos MT, Coutinho RA. Frequent injecting
impairs lymphocyte reactivity in HlV-positive and HlV-negative
drug users. AIDS 1991; 5: 33-41.
311. Des Jarlais DC, Friedman SR, Hopkins W. Risk reduction of the
acquired immunodeficiency syndrome among intravenous drug
users, in AIDS and IV Drug Abusers: Current Perspectives, R. P.
Galea, B. F. Lewis and L. Baker (eds.) National Health Publishing,
Owings Mills, MD, 1988; 97-109.
312. Brudney K, Dobkin J. Resurgent tuberculosis in New York City.
Am Rev Respir Dis 1991; 144: 744-749.
313. Koch T. Uninfected children of HlV-infected mothers may still suf-
fer nervous problems. CDC AIDS Weekly 1990; 9, July 30.
314. Aylward EH, Butz AM, Hutton N, Joyner ML, Vogelhut JW.
Cognitive and motor development in infants at risk for human
immunodeficiency virus. AJDC 1992; 146: 218-222.
315. Rogers MF, Ou C-Y, Rayfield M, Thomas PA, Schoenbaum EE,
Abrams E, Krasinski K, Selwyn PA, Moore J, Kaul A, Grimm KT,
Bamji M, Schochetman G, the New York City Collaborative Study
of Maternal HIV Transmission, Montefiori Medical Center HIV
Perinatal Transmission Study Group. Use of the polymerase chain
reaction for early detection of the proviral sequences of human
immunodeficiency virus in infants born to seropositive mothers.
NEJM 1989; 320: 1649-1654.
316. Culver KW, Ammann AJ, Patridge JC, Wong DF, Wara DW, Cowan
MJ. Lymphocyte abnormalities in infants born to drug-abusing
mothers. J Pediatr 1987; 111: 230-235.
317. Scolaro M, Durham R, Pieczenik G. Potential molecular competi-
tor for HIV. Lancet 1991; 337:731-732.
318. Till M, MacDonnell KB. Myopathy with human immunodeficien-
cy virus type 1 (HIV-1) infection: HIV-1 or zidovudine? Ann
Intern Med 1990; 113: 492-494.
319. Gill PS, Rarick M, Byrnes RK, Causey D, Loureiro C, Levine AM.
Azidothymidine associated with bone marrow failure in the acquired
immunodeficiency syndrome (AIDS). Ann Intern Med 1987; 107:
502-505.
320. Freeman E. HIV does not cause AIDS. HealthQuest 1996; 35-49,
Fall 1996.
321. Hughes MD, Stein DS, Gundacker HM, Valentine FT, Phair JP,
Volberding PA. Within-Subject Variation in CD4 Lymphocyte
Count in Asymptomatic Human Immunodeficiency Virus
Infection: Implications for Patient Monitoring. J Infectious Diseases
1994; 169: 28-36.
322. Blanche S, Mayaux M-J, Rouzioux C, Teglas J-P, Firtion G,
Monpoux F, Ciraru-Vigneron N, Meier F, Tricoire J, Courpotin C,
Vilmer E, Griscelli C, Delfraissy J-F, The French Pediatric HIV
Infection Study Group. Relation of the Course of HIV Infection in
Children to the Severity of the Disease in their Mothers at Delivery.
The New England Journal of Medicine 1994; 330: 308-312.
323. The European Collaborative Study. Natural History of Vertically
Acquired Human Immunodeficiency Virus-1 Infection. Pediatrics
1994; 94: 815-819.
324. Friedman SR, Jose B, Deren S, Des Jarlais DC, Neaigus A. Risk
Factors for Human Immunodeficiency Virus Seroconversion among
Out-of-Treatment Drug Injectors in High and Low Seroprevalence
Cities. American Journal of Epidemiology 1995; 142: 864-874.
325. Evenson W. Heroin’s in fashion - and death statistics prove it. San
Francisco Chronicle (San Francisco) 1996: Al, A8, July 30.
326. Centers for Disease Control and Prevention. U.S. HIV and AIDS
cases reported through June 1996. HIV/AIDS Surveillance Report
1996; 8: 1-33.
327. Kramer A. HIV hits former USSR - a small citys story. San
Francisco Chronicle (San Francisco) 1996: A1 & All, November
26.
328. Gallo RC, Sarin PS, Gelmann EP, Robert-Guroff M, Richardson E.
Isolation of human T-cell leukemia virus in acquired immune defi-
ciency syndrome (AIDS). Science 1983; 220: 865-867.
329. Montagnier L, Chermann JC, Barré-Sinoussi F, Chamaret S, Gruest
J, Nugeyre MT, Rey F, Dauguet C, Axler-Blin C, Vézinet-Brun F,
Rouzioux C, Saimot G-A, Rozenbaum W, Gluckman JC,
Klatzmann D, Vilmer E, Griscelli C, Foyer-Gazengel C, Brunet JB.
A new human T-lymphotropic retrovirus: Characterization and pos-
sible role in lymphadenopathy and acquired immune deficiency syn-
dromes, in Human T-Cell Leukemia/Lymphona Virus; The Family
of Human T-Lymphotropic Retroviruses: Their Role in
Malignancies and Association with AIDS, R. C. Gallo, M. E. Essex
and L. Gross (eds.) Cold Spring Harbor Laboratory, Cold Spring
Harbor, NY, 1984; 363-379.
330. Centers for Disease Control. An evaluation of the immunotoxic
potential of isobutyl nitrite. MMWR 1983; 32: 457-464.
331. McKeown T. The Role of Medicine: Dream, Mirage, or Nemesis?
Princeton University Press, Princeton, NJ, 1979.
332. Kolata G. Anthropologists suggest cannibalism is a myth. Science
1986; 232: 1497-1500.
333. Stolberg S. Studies rebut controversial AIDS theory. Los Angeles
Times (Los Angeles) 1993: A18, March 11.
334. Perlman D. Biologists theory on AIDS attacked. San Francisco
Chronicle (San Francisco) 1993: A10, March 11.
335. Duesberg P. HIV and the aetiology of AIDS. Lancet 1993; 341:
957-958.
336. Duesberg P. AIDS Data. Science 1995; 268: 350-351.
337. Ascher M, Sheppard HW, Winkelstein W. AIDS Data. Science
1995; 268: 351-352.
338. Klimas NG, Blaney NT, Morgan RO, Chitwood D, Milles K, Lee
H, Fletcher MA. Immune Function and Anti-HTLV-I/II Status in
Anti-HIV-l-Negative Intravenous Drug Users Receiving
Methadone. The American Journal of Medicine 1991; 90: 163-170.
339. Schechter MT, Craib KJP, Gelmon KA, Montaner JSG, Le TN,
O’Shaughnessy MV. HIV-1 and the aetiology of AIDS. Lancet
1993; 341: 658-659.
340. Smith GD, Phillips AN. Confounding in epidemiological studies:
why “independenf’ effects may not be all they seem. BMJ 1992;
305: 757-759.
341. MaddoxJ. Has Duesberg a right of reply? N ature 1993; 363: 109.
342. Koliadin V. Duesberg: rights and wrongs. Nature 1993; 364: 96.
343. Birkett N. “The Duesberg phenomenon”: Duesberg and other voic-
es. Science 1995; 268: 315.
344. Farber C. AIDS - Words from the Front. SPIN Magazine 1995;
189-193,214-215, April.
345. Ostrom N. Early Intervention: An Idea Whose Time Has Gone?
New York Native 1995; 35-39, August 28.
346. Ostrom N. Nightmare on AZT Street. New York Native 1995; 34-
36, September 4.
347. Duesberg P. Duesberg responds (letter). The Scientist 1995: 13,
September 4.
348. Kolata G. Debunking doubts that HIV causes AIDS. The New
York Times (New York) 1993: A11, March 11.
349. Gutknecht G. Letter to Dr. Fauci. (Washington, D.C.) 1995:
March 24.
350. AIDS Weekly. Government Congressman questions funding for
AIDS research. AIDS Weekly (electronic version) 1995; May, 22:
351. Chronicle SF. California winning war on cigarette smoking. San
Francisco Chronicle (San Francisco) 1996: A3, Nov. 8, 1996.
352. McCormackTP. The AIDS benefits handbook: everything you need
to know to get social security, welfare, medicaid, medicare, food
stamps, housing, drugs, and other benefits. Yale University Press,
New Haven, 1990.
LÆKNANEMINN
136 1. tbl. 1997, 50. árg.